Check how courts have cited this case. Use our free citator for the most current treatment.
No. 8622038
United States Court of Appeals for the Ninth Circuit
Bedford Oak Partners, LP v. ICN Pharmaceuticals Inc.
No. 8622038 · Decided June 16, 2006
No. 8622038·Ninth Circuit · 2006·
FlawFinder last updated this page Apr. 2, 2026
Case Details
Court
United States Court of Appeals for the Ninth Circuit
Decided
June 16, 2006
Citation
No. 8622038
Disposition
See opinion text.
Full Opinion
MEMORANDUM * Appellants contend that the allegations at issue in its First Amended Complaint and Second Amended Complaint satisfy the stringent pleading requirements of the Private Securities Litigation Reform Act. We disagree. The allegations at issue lack the critical details necessary to establish falsity or raise a strong inference of scienter. See In re Daou Sys., Inc., Sec. Litig., 411 F.3d 1006, 1014-15 (9th Cir.2005). AFFIRMED. This disposition is not appropriate for publication and may not be cited to or by the courts of this circuit except as provided by Ninth Circuit Rule 36-3.
Plain English Summary
MEMORANDUM * Appellants contend that the allegations at issue in its First Amended Complaint and Second Amended Complaint satisfy the stringent pleading requirements of the Private Securities Litigation Reform Act.
Key Points
01MEMORANDUM * Appellants contend that the allegations at issue in its First Amended Complaint and Second Amended Complaint satisfy the stringent pleading requirements of the Private Securities Litigation Reform Act.
02The allegations at issue lack the critical details necessary to establish falsity or raise a strong inference of scienter.
03This disposition is not appropriate for publication and may not be cited to or by the courts of this circuit except as provided by Ninth Circuit Rule 36-3.
04
Frequently Asked Questions
MEMORANDUM * Appellants contend that the allegations at issue in its First Amended Complaint and Second Amended Complaint satisfy the stringent pleading requirements of the Private Securities Litigation Reform Act.
FlawCheck shows no negative treatment for Bedford Oak Partners, LP v. ICN Pharmaceuticals Inc. in the current circuit citation data.
This case was decided on June 16, 2006.
Use the citation No. 8622038 and verify it against the official reporter before filing.